AZACITIDINE TEVA Israel - English - Ministry of Health

azacitidine teva

abic marketing ltd, israel - azacitidine - lyophilized powder for suspension for sc injection / solution for infusion - azacitidine 100 mg/vial - azacitidine - azacitidine teva is indicated for treatment of patients with the following french-american- british (fab) myelodysplastic syndrome subtypes: refractory anemia (ra) or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (raeb), refractory anemia with excess blasts in transformation (raeb-t), and chronic myelomonocytic leukemia (cmmol).

LONQUEX Israel - English - Ministry of Health

lonquex

abic marketing ltd, israel - lipegfilgrastim - solution for injection - lipegfilgrastim 6 mg / 0.6 ml - lipegfilgrastim - reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).

QVAR 50 Israel - English - Ministry of Health

qvar 50

abic marketing ltd, israel - beclometasone dipropionate - inhaler - beclometasone dipropionate 50 mcg/dose - beclometasone - beclometasone - prophylaxis and treatment of bronchial asthma in adults and children 5 years of age and obove.

QVAR 100 Israel - English - Ministry of Health

qvar 100

abic marketing ltd, israel - beclometasone dipropionate - inhaler - beclometasone dipropionate 100 mcg/dose - beclometasone - prophylaxis and treatment of bronchial asthma in adults and children 5 years of age and obove.

QVAR 100 Israel - English - Ministry of Health

qvar 100

abic marketing ltd, israel - beclometasone dipropionate - inhaler - beclometasone dipropionate 100 mcg/dose - beclometasone - prophylaxis and treatment of bronchial asthma in adults and children 5 years of age and obove.

OPTALGIN  DROPS NEW Israel - English - Ministry of Health

optalgin drops new

abic marketing ltd, israel - dipyrone - drops - dipyrone 500 mg / 1 ml - metamizole sodium - relief of moderate to severe pain as in headache, toothache, dysmenorrhea and for high fever that does not respond to other measures.

BORTEZ TEVA 3.5 MG Israel - English - Ministry of Health

bortez teva 3.5 mg

abic marketing ltd, israel - bortezomib - powder for solution for injection - bortezomib 3.5 mg - bortezomib - bortezo teva is indicated for the treatment of patients with multiple myeloma. bortezo teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. bortezo teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.

FLUOROURACIL TEVA Israel - English - Ministry of Health

fluorouracil teva

abic marketing ltd, israel - fluorouracil - solution for injection - fluorouracil 50 mg/ml - fluorouracil - fluorouracil - palliative management of carcinoma of the colon, rectum, breast, stomach and pancreas, in selected patients considered incurable by surgery or other means.as leucovorin-fluorouracil chemotherapy combination for cancer treatment.

ACTIQ 200 MCG Israel - English - Ministry of Health

actiq 200 mcg

abic marketing ltd, israel - fentanyl as citrate - compressed tablet on a handle - fentanyl as citrate 200 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

ACTIQ 400 MCG Israel - English - Ministry of Health

actiq 400 mcg

abic marketing ltd, israel - fentanyl as citrate - compressed tablet on a handle - fentanyl as citrate 400 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.